Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens

Name: Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
License: Public Domain

Shionogi

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

healthcare

healthcare-associated pneumonia (hcap), bloodstream infections (bsi), hospital acquired pneumonia (hap), complicated urinary tract infection (cuti), sepsis, ventilator associated pneumonia (vap)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 300275
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.